STOCK TITAN

Chime director-linked funds sell 447K shares

Director-linked investment funds sold 447,637 CHYM shares in mid-September 2026 while retaining significant indirect and direct holdings.

(Very High)
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

Chime Financial, Inc. (CHYM) director James Feuille reported that investment entities and trusts associated with him sold a total of 447,637 shares of Class A Common Stock between September 14 and September 16, 2026 in open-market transactions at weighted-average prices within disclosed ranges. Following these trades and prior exempt in-kind fund distributions, he continues to report indirect holdings through Crosslink funds and trusts, plus 23,315 shares held directly, while disclaiming beneficial ownership except to the extent of his pecuniary interest.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Feuille James
Role Director
Sold 447,637 shs ($14.72M)
Type Security Shares Price Value
Sale Class A Common Stock F5, F2 62,218 $31.46 $1.96M
Sale Class A Common Stock F6, F2 33,182 $32.19 $1.07M
Sale Class A Common Stock F7, F8, F9, F10 161,437 $32.70 $5.28M
Sale Class A Common Stock F4, F2 94,446 $33.20 $3.14M
Sale Class A Common Stock F2 954 $33.95 $32K
Sale Class A Common Stock F1, F2 93,428 $34.08 $3.18M
Sale Class A Common Stock F3, F2 1,972 $34.41 $68K
holding Class A Common Stock F11, F12 -- -- --
holding Class A Common Stock F13, F14 -- -- --
holding Class A Common Stock F15, F16 -- -- --
holding Class A Common Stock F17, F18 -- -- --
holding Class A Common Stock F19 -- -- --
holding Class A Common Stock -- -- --
Holdings After Transaction: Class A Common Stock — 6,560,707 shares (Indirect, By Crosslink Crossover Fund VI, L.P.); Class A Common Stock — 0 shares (Indirect, By Crosslink Ventures VII Holdings, LLC); Class A Common Stock — 8,275,067 shares (Indirect, By Crosslink Ventures VII, L.P.); Class A Common Stock — 3,545,896 shares (Indirect, Crosslink Ventures VII-B, L.P.); Class A Common Stock — 876,661 shares (Indirect, By Crosslink Bayview VII, LLC); Class A Common Stock — 193,992 shares (Indirect, By Trust); Class A Common Stock — 23,315 shares (Direct)
Footnotes (19)
  1. F1. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $33.36 to $34.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
  2. F2. Shares are directly held by Crosslink Crossover Fund VI, L.P. ("CO VI"). Crossover Fund VI Management, L.L.C. ("CF VI Mgr") is the general partner of CO VI and the Reporting Person is a managing member of CF VI Mgr. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  3. F3. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $34.40 to $34.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
  4. F4. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $32.90 to $33.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
  5. F5. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $30.87 to $31.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
  6. F6. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $31.87 to $32.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
  7. F7. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $32.38 to $33.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
  8. F8. The shares held by Crosslink Ventures VII Holdings, LLC ("CV VII Hldgs") as reported herein reflect the receipt of shares pursuant to pro rata distributions in kind, effected by CB VII and CB VII-B, for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
  9. F9. The shares held by CV VII Hldgs as reported herein reflect pro rata distributions in kind, effected by CV VII Hldgs to its members for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
  10. F10. Shares are directly held by CV VII Hldgs. The Reporting Person is a managing member of CV VII Hldgs and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  11. F11. The shares held by Crosslink Ventures VII, L.P. ("CV VII") as reported herein reflect pro rata distributions in kind, effected by CV VII to its general partner and limited partners for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
  12. F12. Shares are directly held by CV VII. Crosslink Ventures VII Holdings, LLC ("CV VII Hldgs") is the general partner of CV VII and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  13. F13. The shares held by Crosslink Ventures VII-B, L.P. ("CV VII-B") as reported herein reflect pro rata distributions in kind, effected by CV VII-B to its general partner and limited partners for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
  14. F14. Shares are directly held by CV VII-B. CV VII Hldgs is the general partner of CV VII-B and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  15. F15. The shares held by Crosslink Bayview VII, LLC ("CB VII") as reported herein reflect pro rata distributions in kind, effected by CB VII to its members for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
  16. F16. Shares are directly held by CB VII. CV VII Hldgs is the manager of CB VII and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  17. F17. The shares reported herein reflect the receipt of shares pursuant to a pro rata distribution in kind, effected by CB VII, for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
  18. F18. The shares are held by an irrevocable trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interest therein.
  19. F19. The shares are held by a revocable trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interest therein.
Total shares sold 447,637 shares Net shares sold by associated entities between September 14–16, 2026
Largest single reported sale 161,437 shares Shares sold by Crosslink Ventures VII Holdings, LLC on September 16, 2026
Sale price range $30.87–$34.41 per share Price ranges for weighted-average sale prices noted in footnotes
Holding by Crosslink Ventures VII, L.P. 8,275,067 shares Indirectly held after reported transactions
Holding by Crosslink Ventures VII-B, L.P. 3,545,896 shares Indirectly held after reported transactions
Holding by Crosslink Bayview VII, LLC 876,661 shares Indirectly held after reported transactions
Directly held shares 23,315 shares Shares held directly by the reporting person
Shares remaining in CV VII Holdings 0 shares Post-transaction balance for Crosslink Ventures VII Holdings, LLC
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
pro rata distributions in kind financial
"reflect pro rata distributions in kind, effected by CV VII to its general"
Rule 16a-13 regulatory
"which were exempt from reporting pursuant to Rule 16a-13."
pecuniary interest financial
"disclaims beneficial ownership of these shares except to the extent of his pecuniary interest"
irrevocable trust financial
"The shares are held by an irrevocable trust, of which the Reporting Person"
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
revocable trust financial
"The shares are held by a revocable trust, of which the Reporting Person"
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Chime Financial (CHYM) director James Feuille report in this Form 4?

He reported that entities and trusts associated with him sold 447,637 shares of Chime Financial Class A Common Stock in open-market transactions from September 14–16, 2026, and he continues to report significant indirect fund- and trust-held positions plus 23,315 shares held directly.

How many CHYM shares were sold and over what dates?

A total of 447,637 shares of Chime Financial Class A Common Stock were sold by associated entities on September 14, 15, and 16, 2026, as reflected across seven sale entries in the Form 4 transaction table.

At what prices were the CHYM shares sold in this Form 4?

Reported per-share sale prices range from $30.87 to $34.41. Several entries note a weighted average price, with shares sold in multiple transactions within specific price ranges detailed in the footnotes.

What CHYM holdings does James Feuille report after these transactions?

He reports indirect holdings of 8,275,067 shares by Crosslink Ventures VII, L.P., 3,545,896 shares by Crosslink Ventures VII-B, L.P., 876,661 shares by Crosslink Bayview VII, LLC, additional trust-held shares, and 23,315 shares held directly.

Does this CHYM Form 4 indicate trades under a Rule 10b5-1 plan?

No. The document-level Rule 10b5-1 checkbox is not affirmed, and the footnotes describing these sales and distributions do not state that they were executed pursuant to a Rule 10b5-1 trading plan.

Does James Feuille claim full beneficial ownership of the reported CHYM shares?

No. Multiple footnotes state that the shares are held by Crosslink funds or trusts, and that he disclaims beneficial ownership of those shares except to the extent of his proportionate pecuniary interest in each entity or trust.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Feuille James

(Last)(First)(Middle)
C/O CHIME FINANCIAL, INC.
101 CALIFORNIA STREET, SUITE 500

(Street)
SAN FRANCISCO CALIFORNIA 94111

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Chime Financial, Inc. [ CHYM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock09/14/2026S93,428D$34.08(1)6,753,479IBy Crosslink Crossover Fund VI, L.P.(2)
Class A Common Stock09/14/2026S1,972D$34.41(3)6,751,507IBy Crosslink Crossover Fund VI, L.P.(2)
Class A Common Stock09/15/2026S94,446D$33.2(4)6,657,061IBy Crosslink Crossover Fund VI, L.P.(2)
Class A Common Stock09/15/2026S954D$33.956,656,107IBy Crosslink Crossover Fund VI, L.P.(2)
Class A Common Stock09/16/2026S62,218D$31.46(5)6,593,889IBy Crosslink Crossover Fund VI, L.P.(2)
Class A Common Stock09/16/2026S33,182D$32.19(6)6,560,707IBy Crosslink Crossover Fund VI, L.P.(2)
Class A Common Stock09/16/2026S161,437D$32.7(7)0(8)(9)IBy Crosslink Ventures VII Holdings, LLC(10)
Class A Common Stock8,275,067(11)IBy Crosslink Ventures VII, L.P.(12)
Class A Common Stock3,545,896(13)ICrosslink Ventures VII-B, L.P.(14)
Class A Common Stock876,661(15)IBy Crosslink Bayview VII, LLC(16)
Class A Common Stock148,746(17)IBy Trust(18)
Class A Common Stock45,246IBy Trust(19)
Class A Common Stock23,315D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $33.36 to $34.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
2. Shares are directly held by Crosslink Crossover Fund VI, L.P. ("CO VI"). Crossover Fund VI Management, L.L.C. ("CF VI Mgr") is the general partner of CO VI and the Reporting Person is a managing member of CF VI Mgr. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
3. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $34.40 to $34.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
4. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $32.90 to $33.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
5. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $30.87 to $31.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
6. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $31.87 to $32.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
7. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $32.38 to $33.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
8. The shares held by Crosslink Ventures VII Holdings, LLC ("CV VII Hldgs") as reported herein reflect the receipt of shares pursuant to pro rata distributions in kind, effected by CB VII and CB VII-B, for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
9. The shares held by CV VII Hldgs as reported herein reflect pro rata distributions in kind, effected by CV VII Hldgs to its members for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
10. Shares are directly held by CV VII Hldgs. The Reporting Person is a managing member of CV VII Hldgs and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
11. The shares held by Crosslink Ventures VII, L.P. ("CV VII") as reported herein reflect pro rata distributions in kind, effected by CV VII to its general partner and limited partners for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
12. Shares are directly held by CV VII. Crosslink Ventures VII Holdings, LLC ("CV VII Hldgs") is the general partner of CV VII and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
13. The shares held by Crosslink Ventures VII-B, L.P. ("CV VII-B") as reported herein reflect pro rata distributions in kind, effected by CV VII-B to its general partner and limited partners for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
14. Shares are directly held by CV VII-B. CV VII Hldgs is the general partner of CV VII-B and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
15. The shares held by Crosslink Bayview VII, LLC ("CB VII") as reported herein reflect pro rata distributions in kind, effected by CB VII to its members for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
16. Shares are directly held by CB VII. CV VII Hldgs is the manager of CB VII and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
17. The shares reported herein reflect the receipt of shares pursuant to a pro rata distribution in kind, effected by CB VII, for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
18. The shares are held by an irrevocable trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interest therein.
19. The shares are held by a revocable trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interest therein.
/s/ James Feuille09/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading